Russian vaccines against especially dangerous bacterial pathogens

In response to the epidemiological situation, live attenuated or killed vaccines against anthrax, brucellosis, cholera, glanders, plague and tularemia were developed and used for immunization of at-risk populations in the Former Soviet Union. Certain of these vaccines have been updated and currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Feodorova, Valentina A, Sayapina, Lidiya V, Corbel, Michael J, Motin, Vladimir L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317636/
https://www.ncbi.nlm.nih.gov/pubmed/26038506
http://dx.doi.org/10.1038/emi.2014.82
_version_ 1782355709672816640
author Feodorova, Valentina A
Sayapina, Lidiya V
Corbel, Michael J
Motin, Vladimir L
author_facet Feodorova, Valentina A
Sayapina, Lidiya V
Corbel, Michael J
Motin, Vladimir L
author_sort Feodorova, Valentina A
collection PubMed
description In response to the epidemiological situation, live attenuated or killed vaccines against anthrax, brucellosis, cholera, glanders, plague and tularemia were developed and used for immunization of at-risk populations in the Former Soviet Union. Certain of these vaccines have been updated and currently they are used on a selective basis, mainly for high risk occupations, in the Russian Federation. Except for anthrax and cholera these vaccines currently are the only licensed products available for protection against the most dangerous bacterial pathogens. Development of improved formulations and new products is ongoing.
format Online
Article
Text
id pubmed-4317636
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43176362015-02-13 Russian vaccines against especially dangerous bacterial pathogens Feodorova, Valentina A Sayapina, Lidiya V Corbel, Michael J Motin, Vladimir L Emerg Microbes Infect Review In response to the epidemiological situation, live attenuated or killed vaccines against anthrax, brucellosis, cholera, glanders, plague and tularemia were developed and used for immunization of at-risk populations in the Former Soviet Union. Certain of these vaccines have been updated and currently they are used on a selective basis, mainly for high risk occupations, in the Russian Federation. Except for anthrax and cholera these vaccines currently are the only licensed products available for protection against the most dangerous bacterial pathogens. Development of improved formulations and new products is ongoing. Nature Publishing Group 2014-12 2014-12-17 /pmc/articles/PMC4317636/ /pubmed/26038506 http://dx.doi.org/10.1038/emi.2014.82 Text en Copyright © 2014 Shanghai Shangyixun Cultural Communication Co., Ltd http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Review
Feodorova, Valentina A
Sayapina, Lidiya V
Corbel, Michael J
Motin, Vladimir L
Russian vaccines against especially dangerous bacterial pathogens
title Russian vaccines against especially dangerous bacterial pathogens
title_full Russian vaccines against especially dangerous bacterial pathogens
title_fullStr Russian vaccines against especially dangerous bacterial pathogens
title_full_unstemmed Russian vaccines against especially dangerous bacterial pathogens
title_short Russian vaccines against especially dangerous bacterial pathogens
title_sort russian vaccines against especially dangerous bacterial pathogens
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317636/
https://www.ncbi.nlm.nih.gov/pubmed/26038506
http://dx.doi.org/10.1038/emi.2014.82
work_keys_str_mv AT feodorovavalentinaa russianvaccinesagainstespeciallydangerousbacterialpathogens
AT sayapinalidiyav russianvaccinesagainstespeciallydangerousbacterialpathogens
AT corbelmichaelj russianvaccinesagainstespeciallydangerousbacterialpathogens
AT motinvladimirl russianvaccinesagainstespeciallydangerousbacterialpathogens

Ejemplares similares